Arenamide B

General Information


DRACP ID  DRACP04196

Peptide Name   Arenamide B

Sequence  AFXGVL

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Bacteria

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C25H37N5O5

Absent amino acids  CDEHIKMNPQRSTWY

Common amino acids  AFGLVX

Mass  68697

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  4

Net charge  0

Boman Index  1469

Hydrophobicity  203.33

Aliphatic Index  130

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 19117399

Title  Arenamides A-C, cytotoxic NFkappaB inhibitors from the marine actinomycete Salinispora arenicola

Doi Not available

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18457

DRACP is developed by Dr.Zheng's team.